Consulting in clinical drug safety, pharmacovigilance, and medical product epidemiology since 1988!


The Degge Group, Ltd., A PharmaLex Company

Located just outside WASHINGTON DC, The Degge Group, a PharmaLex Company, provides consulting services to the biopharmaceutical and medical products sector specializing in clinical drug safety, pharmacovigilance, medical product epidemiology, and risk management.

Degge's staff has contributed to the burgeoning fields of pharmacoepidemiology and pharmacovigilance for over two decades and has worked to enhance the understanding of drug safety, drug use, natural history of disease studies, risk evaluation and mitigation strategies (REMS), benefit-risk assessments, and pharmacoeconomic and outcomes research.

Degge will help you identify and analyze key data to meet your needs.

Announcements



  

Judith K Jones, MD, PhD,FISPE, President of The Degge Group, Ltd. (a PharmaLex company), will speak at the International Society for Pharmacoepidemiology’s 10th Annual Asian Conference on Pharmacoepidemiology (ACPE) in Brisbane, Australia, October 29-31, 2017. She will present her views on the promise and pitfalls of Big Data on Sunday, October 29. Stop by to say hello to her if you are at ACPE or contact us for more details on our pharmacoepidemiology capabilities.




Degge was a Gold Sponsor (and Exhibitor) for the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, August 26 – 30, 2017 in Montreal, Canada.

Our Poster Presentations:
  • Degge Poster, Aug 28th - Testing the Validity of Comparative Reproductive Tract Cancer Rates Combining Two Methods of Subject Identification in a Large Cohort Study of Rural Northern Vietnamese Women
  • DGI/B.R.I.D.G.E. TO DATA® Poster, Aug 30th - Challenges and Solutions for Globally Establishing and Standardizing Population Healthcare Databases

The winner of our Echo Dot raffle was Denise Oleske. Congratulations, Denise!

As of April 24, 2017, The Degge Group, Ltd. has become a member of PharmaLex GmbH (Friedrichsdorf, Germany), an international consortium of small companies similar to Degge but with different areas of scientific expertise and focus in the biopharma industry. We are pleased about joining PharmaLex’s group of companies. The impact of Degge’s joining PharmaLex will primarily be felt in our Research and Regulatory Consulting Divisions, which will be enhanced by additional PharmaLex expertise and services. Read More


Our recent publication: Measures That Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: ACTTION Critique and Recommended Considerations was recently published in Journal of Pain. Coauthors included Shannon M Smith and Judith K Jones, MD, PhD, FISPE.

Contact Us

The Degge Group, Ltd.
A PHARMALEX Company
9302 Lee Highway, Suite 700
Fairfax, VA 22031 USA
P: +1 (571) 490-8020
F: +1 (571) 490-8408
E: info@deggegroup.com
S: LinkedIn
O: Online Form

 Degge Crest
A PHARMALEX Company




      Services


REMS

      Risk Management /
      Risk Evaluation &
      Mitigation Strategies






Pharmacoepi

Pharmacoepidemiology Research






HEOR

Pharmacoeconomic and Outcomes Research


PV

      Pharmacovigilance

Regulatory

Regulatory Affairs - US and International


OSG

Oversight Group Management


SBIR Grants

      Government Grants





Legal

Regulatory Medical-Legal

For scientific support in medico-legal affairs please contact Degge's Senior Legal Services Manager through our online form.


Regulatory

Graduate Internship Program


© 2017 The Degge Group Ltd., All Rights Reserved

Icons made by Freepik, Designmodo and is licensed by CC BY 3.0